News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
39,767 Results
Type
Article (2548)
Company Profile (45)
Press Release (37174)
Multimedia
Podcasts (9)
Webinars (2)
Section
Business (14186)
Career Advice (78)
Deals (2097)
Drug Delivery (9)
Drug Development (4138)
Employer Resources (10)
FDA (439)
Job Trends (780)
News (20251)
Policy (1055)
Tag
Academia (144)
Allergies (7)
Alliances (3490)
ALS (5)
Alzheimer's disease (52)
Antibody-drug conjugate (ADC) (23)
Approvals (438)
Artificial intelligence (26)
Autoimmune disease (8)
Automation (2)
Bankruptcy (12)
Best Places to Work (476)
BIOSECURE Act (2)
Biosimilars (16)
Biotechnology (29)
Bladder cancer (8)
Brain cancer (6)
Breast cancer (38)
Cancer (292)
Cardiovascular disease (8)
Career advice (66)
Career pathing (1)
CAR-T (27)
CDC (1)
Cell therapy (74)
Cervical cancer (2)
Clinical research (3390)
Collaboration (170)
Company closure (2)
Compensation (91)
COVID-19 (183)
CRISPR (11)
C-suite (93)
Cystic fibrosis (6)
Data (360)
Denatured (6)
Depression (10)
Diabetes (16)
Diagnostics (478)
Digital health (2)
Diversity (2)
Diversity, equity & inclusion (1)
Drug discovery (26)
Drug pricing (10)
Duchenne muscular dystrophy (36)
Earnings (4484)
Editorial (4)
Employer branding (1)
Employer resources (8)
Events (6347)
Executive appointments (129)
FDA (560)
Friedreich's ataxia (1)
Frontotemporal dementia (1)
Funding (144)
Gene editing (30)
Generative AI (1)
Gene therapy (45)
GLP-1 (63)
Government (157)
Guidances (23)
Healthcare (707)
Huntington's disease (5)
IgA nephropathy (11)
Immunology and inflammation (31)
Immuno-oncology (8)
Indications (4)
Infectious disease (191)
Inflammatory bowel disease (15)
Inflation Reduction Act (6)
Influenza (7)
Intellectual property (24)
Interviews (7)
IPO (1001)
IRA (7)
Job creations (293)
Job search strategy (62)
Kidney cancer (6)
Labor market (11)
Layoffs (49)
Leadership (3)
Legal (215)
Liver cancer (6)
Longevity (1)
Lung cancer (27)
Lymphoma (10)
Machine learning (1)
Management (4)
Manufacturing (43)
MASH (12)
Medical device (310)
Medtech (310)
Mergers & acquisitions (1202)
Metabolic disorders (64)
Multiple sclerosis (20)
Neurodegenerative disease (22)
Neuropsychiatric disorders (6)
Neuroscience (145)
NextGen: Class of 2025 (353)
Non-profit (154)
Now hiring (10)
Obesity (27)
Opinion (17)
Ovarian cancer (17)
Pain (21)
Pancreatic cancer (20)
Parkinson's disease (9)
Partnered (2)
Patents (48)
Patient recruitment (20)
Peanut (1)
People (5837)
Pharmaceutical (5)
Phase I (1454)
Phase II (1685)
Phase III (900)
Pipeline (289)
Policy (15)
Postmarket research (30)
Preclinical (637)
Press Release (2)
Prostate cancer (7)
Psychedelics (2)
Radiopharmaceuticals (13)
Rare diseases (50)
Real estate (424)
Recruiting (5)
Regulatory (890)
Reports (7)
Research institute (147)
Resumes & cover letters (9)
Rett syndrome (1)
RNA editing (5)
Schizophrenia (15)
Series A (38)
Series B (18)
Service/supplier (2)
Sickle cell disease (2)
Special edition (3)
Spinal muscular atrophy (2)
Sponsored (1)
Startups (496)
Stomach cancer (2)
Supply chain (4)
Tariffs (1)
The Weekly (3)
Vaccines (46)
Venture capital (13)
Weight loss (21)
Women's health (8)
Worklife (1)
Date
Last 7 days (46)
Last 30 days (194)
Last 365 days (2421)
2025 (2313)
2024 (2611)
2023 (2858)
2022 (3755)
2021 (4052)
2020 (3471)
2019 (2061)
2018 (1554)
2017 (1798)
2016 (1625)
2015 (1833)
2014 (1369)
2013 (1188)
2012 (1396)
2011 (1332)
2010 (1181)
Location
Africa (44)
Alabama (2)
Arizona (16)
Asia (1926)
Australia (305)
California (1471)
Canada (228)
China (69)
Colorado (45)
Connecticut (14)
Delaware (4)
Europe (3989)
Florida (61)
Georgia (11)
Hawaii (2)
Idaho (3)
Illinois (18)
India (2)
Indiana (52)
Japan (14)
Kansas (14)
Kentucky (1)
Maryland (44)
Massachusetts (515)
Michigan (13)
Minnesota (20)
Mississippi (1)
Missouri (4)
Nebraska (1)
Nevada (3)
New Hampshire (2)
New Jersey (125)
New York (73)
North Carolina (127)
Northern California (696)
Ohio (40)
Oklahoma (2)
Oregon (5)
Pennsylvania (96)
Puerto Rico (1)
Rhode Island (2)
South America (40)
South Carolina (1)
Southern California (609)
Tennessee (4)
Texas (138)
United States (2931)
Utah (4)
Virginia (10)
Washington D.C. (2)
Washington State (85)
West Virginia (1)
Wisconsin (10)
39,767 Results for "caladrius bioscience".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Droplet Biosciences-Study Reveals Post-Surgical Lymph Fluid as a Powerful Source of ctDNA for Early Recurrence Detection in Head & Neck Cancer
November 14, 2025
·
4 min read
Press Releases
Alligator Bioscience Publishes Financial Calendar for 2026
December 3, 2025
·
1 min read
Deals
Caladrius Biosciences and Cend Therapeutics Announce Closing of Merger and the Emergence of Lisata Therapeutics
Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius”) and Cend Therapeutics, Inc. (“Cend”) today announced that the proposed merger of the two companies has closed following the approval of Caladrius’ stockholders on September 13, 2022.
September 15, 2022
·
8 min read
Press Releases
Parse Biosciences Launches Evercode Whole Blood Fixation
December 4, 2025
·
2 min read
Press Releases
Chromatin Bioscience Announces Collaboration with Purespring Therapeutics
October 28, 2025
·
2 min read
Press Releases
Skye Bioscience to Participate in Upcoming Investment Conferences
November 24, 2025
·
1 min read
Press Releases
Solid Biosciences Announces Licensing Agreement with Andelyn Biosciences for the Use of Proprietary Next-Generation Capsid AAV-SLB101
November 18, 2025
·
8 min read
Press Releases
Daré Bioscience Receives $3.6 Million in Additional Grant Funding
November 24, 2025
·
10 min read
Press Releases
PURE Bioscience, Inc. Announces Leadership Promotions
November 20, 2025
·
3 min read
Press Releases
FDA Grants Fast Track Designation to Cothera Bioscience’s Zotiraciclib for Treatment of Recurrent High-Grade Glioma with IDH1/2 Mutations
Breakthrough oral CDK9 inhibitor advances care for patients with recurrent high-grade gliomas harboring IDH1/2 mutations
November 26, 2025
·
1 min read
1 of 3,977
Next
